ConductScience.org, home

Library / Genes

DMD: dystrophin

1 protein, 28 patents, 8 drugs, 43 trials, 4,298 NIH grants and 12,592 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolDMDHGNC
NamedystrophinHGNC
NCBI Gene ID1756NCBI Gene
HGNC IDHGNC:2928HGNC
EnsemblENSG00000198947NCBI Gene
AliasesBMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P11532Dystrophin3,6856Ensembl, GeneID, HGNCUniProt

Patents 28

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4793284 A22026-08-194P11532Espacenet
JP 2026515786 A2026-05-1935P11532Espacenet
JP 2026004568 A2026-01-1444591P11532Espacenet
EP 4650780 A22025-11-197970P11532Espacenet
EP 4640849 A22025-10-291205P11532Espacenet
EP 4641201 A22025-10-298072P11532Espacenet
JP 2025098002 A2025-07-014P11532Espacenet
JP 2025519096 A2025-06-241205P11532Espacenet
JP 2025517969 A2025-06-128072P11532Espacenet
JP 2025517970 A2025-06-127970P11532Espacenet

Drugs 8

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
CASIMERSENCHEMBL4297566Dystrophin pre-mRNA positive modulatorPOSITIVE MODULATORChEMBL
DELANDISTROGENE MOXEPARVOVECCHEMBL4650241Dystrophin exogenous geneEXOGENOUS GENEChEMBL
DRISAPERSENCHEMBL2108735Dystrophin pre-mRNA positive modulatorPOSITIVE MODULATORChEMBL
ETEPLIRSENCHEMBL2108278Dystrophin pre-mRNA positive modulatorPOSITIVE MODULATORChEMBL
GOLODIRSENCHEMBL4297762Dystrophin pre-mRNA positive modulatorPOSITIVE MODULATORChEMBL
SUVODIRSENCHEMBL4298192Dystrophin pre-mRNA positive modulatorPOSITIVE MODULATORChEMBL
SUVODIRSEN SODIUMCHEMBL4298193Dystrophin pre-mRNA positive modulatorPOSITIVE MODULATORChEMBL
VILTOLARSENCHEMBL4298062Dystrophin pre-mRNA positive modulatorPOSITIVE MODULATORChEMBL

Trials 43

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT06606340ETEPLIRSENClinicalTrials.gov
NCT06606340CASIMERSENClinicalTrials.gov
NCT06606340GOLODIRSENClinicalTrials.gov
NCT06270719DELANDISTROGENE MOXEPARVOVECClinicalTrials.gov
NCT06241950DELANDISTROGENE MOXEPARVOVECPHASE1ClinicalTrials.gov
NCT04956289VILTOLARSENPHASE22024-08-20ClinicalTrials.gov
NCT04768062VILTOLARSENPHASE3ClinicalTrials.gov
NCT04708314GOLODIRSENPHASE4ClinicalTrials.gov
NCT04687020VILTOLARSENPHASE4ClinicalTrials.gov
NCT04337112VILTOLARSENClinicalTrials.gov

NIH grants 4298

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
R01AR042423Cytoskeletal Interactions of Dystrophin352,025NIH's project files
R01AR040864Dystrophin Replacement332,025NIH's project files
R01NS090634Whole body single AAV microgene in canine DMD272,025NIH's project files
T32AR007612Minnesota Muscle Training Program222,025NIH's project files
ZIANS003129Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies192,025NIH's project files
R01NS047726Mechanisms of resealing and rebuilding in muscle repair132,025NIH's project files
P50AR065139Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center - Seattle122,025NIH's project files
P50NS053672Muscular Dystrophy Specialized Research Center122,025NIH's project files
T32AG029796Functional Multi-omics of Aging122,025NIH's project files
R01NS085238Genetic modifiers of Duchenne Muscular Dystrophy112,025NIH's project files

Papers 12592

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42820057PubTator, text miningPubMed
42816542PubTator, text miningPubMed
42800828PubTator, text miningPubMed
42788239PubTator, text miningPubMed
42784204PubTator, text miningPubMed
42779831PubTator, text miningPubMed
42778113PubTator, text miningPubMed
42771065PubTator, text miningPubMed
42750973PubTator, text miningPubMed
42749483PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license